c-Myc tag Peptide (A6003): Mechanism, Evidence, and Applications

Executive Summary: The c-Myc tag Peptide is a synthetic peptide corresponding to amino acids 410–419 of human c-Myc, used for specific displacement of c-Myc-tagged fusion proteins from anti-c-Myc antibodies in immunoassays (APExBIO). It is soluble at ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water with ultrasonication, but insoluble in ethanol. c-Myc is a proto-oncogene transcription factor central to cell proliferation, apoptosis, and cancer biology (Wu et al., 2021). The peptide acts by competitively inhibiting antibody binding, enabling controlled elution and quantification in immunoassay workflows. This review outlines the biological rationale, action mechanism, experimental benchmarks, and common misconceptions for the c-Myc tag Peptide.

Biological Rationale

The c-Myc gene encodes a basic helix-loop-helix leucine zipper transcription factor, regulating genes involved in cell cycle progression, growth, apoptosis, and metabolism (Wu et al., 2021). c-Myc's proto-oncogenic activity arises from its dual role: upregulating cyclins and ribosomal genes, and downregulating cell cycle inhibitors such as p21 and anti-apoptotic factors like Bcl-2. Its dysregulation is a hallmark in numerous cancers. Fusion of a c-Myc tag (EQKLISEEDL, residues 410–419) to recombinant proteins enables their detection and purification via anti-c-Myc antibodies. However, controlled elution and displacement require a competitive peptide reagent, such as the synthetic c-Myc tag Peptide. The peptide provides specificity in immunoassays, minimizing background and increasing detection precision (Related: c-Myc tag Peptide: Advanced Mechanisms—this article extends the mechanistic depth and bench workflow integration for immunoassays).

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide (A6003) functions as a competitive inhibitor for anti-c-Myc antibody binding. In immunoassays, c-Myc-tagged fusion proteins bind anti-c-Myc antibodies immobilized on beads or plates. Introduction of the synthetic peptide at sufficient concentration outcompetes the fusion protein for antibody binding sites, effecting controlled elution or quantification. The peptide sequence (EQKLISEEDL) mimics the C-terminal epitope of c-Myc, ensuring high-specificity displacement. Solubility parameters are critical: ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water with ultrasonication, but insoluble in ethanol (APExBIO). This selectivity allows precise modulation in immunoprecipitation, western blot, or ELISA workflows (Related: Mechanistic Insights and Bench Integration—this review further clarifies solution handling and specificity boundaries).

Evidence & Benchmarks

• The c-Myc tag Peptide (A6003) sequence corresponds precisely to amino acids 410–419 of human c-Myc protein (UniProt P01106), ensuring specificity for anti-c-Myc antibodies (APExBIO).
• Solubility is quantified at ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water (ultrasonicated, room temperature), supporting high-concentration workflows (APExBIO).
• c-Myc is a central proto-oncogene, regulating cell proliferation and apoptosis via transcriptional control of cyclins, ribosomal genes, p21, and Bcl-2 (Wu et al., 2021).
• Competitive displacement of c-Myc-tagged proteins with the peptide enables precise immunoassay quantification and background reduction (Related: Mechanistic Insights for Precision Assays—this article updates solubility and storage guidance).
• The peptide is not intended for diagnostic or clinical use; it is for research applications only (APExBIO).

Applications, Limits & Misconceptions

The c-Myc tag Peptide is used in:

• Displacement of c-Myc-tagged fusion proteins from anti-c-Myc antibodies in immunoprecipitation, western blot, and ELISA assays.
• Antibody binding inhibition studies to validate specificity.
• Research into c-Myc's role in transcriptional regulation, cell proliferation, and oncogenesis.
• Systems biology interrogation of transcription factor networks and autophagy-immune crosstalk in cancer (Related: Systems Biology Insights—this article provides fine-grained peptide usage parameters).

Common Pitfalls or Misconceptions

• The peptide is insoluble in ethanol; attempts to dissolve it in ethanol will fail.
• Peptide solutions are unstable in long-term storage; prepare fresh aliquots as needed.
• The product is not suitable for in vivo or therapeutic use; it is strictly for in vitro research.
• Not all anti-c-Myc antibodies recognize the same epitope; check compatibility with the specific antibody clone used.
• Excessive peptide concentrations may lead to nonspecific inhibition in complex mixtures; titrate for optimal results.

Workflow Integration & Parameters

For optimal use, dissolve the c-Myc tag Peptide (A6003) in DMSO to ≥60.17 mg/mL or in water (with ultrasonic treatment) to ≥15.7 mg/mL. Avoid ethanol as a solvent. Store lyophilized peptide at –20°C in a desiccated environment. Prepare working solutions fresh; avoid freeze-thaw cycles. In displacement assays, titrate peptide concentration to achieve >90% displacement of fusion protein without excess background. Confirm antibody-epitope compatibility prior to use. For immunoprecipitation or ELISA, incubate with peptide for at least 30 minutes at room temperature for efficient competitive binding. Integrate with antibody capture workflows for maximal specificity and minimal cross-reactivity (Related: Strategic Use in Transcription Factor Studies—this article supplies updated solvent and storage benchmarks for rigorous reproducibility).

Conclusion & Outlook

The c-Myc tag Peptide (A6003) from APExBIO is a high-specificity reagent for displacement of c-Myc-tagged proteins in immunoassays, underpinning cancer and transcription factor research. Its defined sequence, solubility profile, and competitive inhibition mechanism make it essential for rigorous, reproducible workflows. As c-Myc continues to be a focus in oncogenic and cell signaling studies, the peptide's role in assay precision and mechanistic exploration will remain significant. Future directions may include integration with high-throughput screening and systems-level studies of c-Myc regulatory networks. For detailed protocols and ordering, refer to the product page.